Unknown

Dataset Information

0

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells.


ABSTRACT: Interest in manipulating the immunosuppressive powers of Foxp3-expressing T regulatory cells as an immunotherapy has been tempered by their reported ability to produce proinflammatory cytokines when manipulated in vitro, or in vivo. Understanding processes that can limit this potentially deleterious effect of Treg cells in a therapeutic setting is therefore important. Here, we have studied this using induced (i) Treg cells in which de novo Foxp3 expression is driven by TCR-stimulation in vitro in the presence of TGF-?. We show that iTreg cells can produce significant amounts of three proinflammatory cytokines (IFN-?, GM-CSF and TNF-?) upon secondary TCR stimulation. GM-CSF is a critical T-cell derived cytokine for the induction of EAE in mice. Despite their apparent capacity to produce GM-CSF, myelin autoantigen-responsive iTreg cells were unable to provoke EAE. Instead, they maintained strong suppressive function in vivo, preventing EAE induction by their CD4+ Foxp3- counterparts. We identified that although iTreg cells maintained the ability to produce IFN-? and TNF-? in vivo, their ability to produce GM-CSF was selectively degraded upon antigen stimulation under inflammatory conditions. Furthermore, we show that IL-6 and IL-27 individually, or IL-2 and TGF-? in combination, can mediate the selective loss of GM-CSF production by iTreg cells.

SUBMITTER: Reynolds BC 

PROVIDER: S-EPMC4257504 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells.

Reynolds Ben C BC   Turner Darryl G DG   McPherson Rhoanne C RC   Prendergast Catriona T CT   Phelps Richard G RG   Turner Neil A NA   O'Connor Richard A RA   Anderton Stephen M SM  

European journal of immunology 20141001 11


Interest in manipulating the immunosuppressive powers of Foxp3-expressing T regulatory cells as an immunotherapy has been tempered by their reported ability to produce proinflammatory cytokines when manipulated in vitro, or in vivo. Understanding processes that can limit this potentially deleterious effect of Treg cells in a therapeutic setting is therefore important. Here, we have studied this using induced (i) Treg cells in which de novo Foxp3 expression is driven by TCR-stimulation in vitro i  ...[more]

Similar Datasets

| S-EPMC6737278 | biostudies-literature
| S-EPMC10050814 | biostudies-literature
| S-EPMC3721510 | biostudies-other
| S-EPMC3705920 | biostudies-literature
| S-EPMC6214726 | biostudies-literature
| S-EPMC3145786 | biostudies-literature
| S-EPMC3879349 | biostudies-literature
| S-EPMC4733039 | biostudies-literature
| S-EPMC5193354 | biostudies-literature
| S-EPMC8275380 | biostudies-literature